OBI has signed a non-binding MOU to form a strategic partnership to develop novel bispecific antibody cancer treatments

Date of occurrence of the event:26 May 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head Office Reciprocal shareholding ratios: No applicable Cause of occurrence: OBI has entered into a non-binding memorandum of understanding with a biotech company intending to form a strategic partnership to develop novel […]